{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "18079018",
  "DateCompleted": {
    "Year": "2008",
    "Month": "03",
    "Day": "25"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0195-6701",
      "JournalIssue": {
        "Volume": "68",
        "Issue": "1",
        "PubDate": {
          "Year": "2008",
          "Month": "Jan"
        }
      },
      "Title": "The Journal of hospital infection",
      "ISOAbbreviation": "J Hosp Infect"
    },
    "ArticleTitle": "Long-term evolution of a nosocomial outbreak of Pseudomonas aeruginosa producing VIM-2 metallo-enzyme.",
    "Pagination": {
      "StartPage": "73",
      "EndPage": "82",
      "MedlinePgn": "73-82"
    },
    "Abstract": {
      "AbstractText": [
        "From April 1996 to July 2004, an outbreak of metallo-beta-lactamase-positive (MBL) Pseudomonas aeruginosa occurred in the haematology ward at Nantes University Hospital in France. Fifty-nine patients were carriers of VIM-2-positive strains of whom 14 were infected (mostly urinary tract infections and pneumonia). Pulsed-field gel electrophoresis identified related isolates demonstrating resistance to all beta-lactams, aminoglycosides, fluoroquinolones, fosfomycin, rifampicin but not colistin. The bla(VIM-2) gene responsible for VIM-2 MBL was not plasmid-encoded but part of a novel type of class 1 integron. VIM-2-positive strains were mostly from urine samples and clinical data suggest that in the absence of therapeutic guidelines, piperacillin-tazobactam or aztreonam may be a reliable choice for treating infections with MBL-producing strains."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Service de Bact\u00e9riologie-Virologie, INSERM U914 Emerging Resistance to Antibiotics H\u00f4pital de Bic\u00eatre, Assistance Publique/H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Paris-Sud, K-Bic\u00eatre, France. stephane.corvec@chu-nantes.fr"
          }
        ],
        "LastName": "Corvec",
        "ForeName": "S",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Poirel",
        "ForeName": "L",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Espaze",
        "ForeName": "E",
        "Initials": "E"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Giraudeau",
        "ForeName": "C",
        "Initials": "C"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Drugeon",
        "ForeName": "H",
        "Initials": "H"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Nordmann",
        "ForeName": "P",
        "Initials": "P"
      }
    ],
    "DataBankList": [
      {
        "DataBankName": "GENBANK",
        "AccessionNumberList": [
          "AY507153"
        ]
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "J Hosp Infect",
    "NlmUniqueID": "8007166",
    "ISSNLinking": "0195-6701"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EC 3.5.2.-",
      "NameOfSubstance": "beta-lactamase bla(vim-2)"
    },
    {
      "RegistryNumber": "EC 3.5.2.6",
      "NameOfSubstance": "beta-Lactamases"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Aged, 80 and over"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Base Sequence"
    },
    {
      "QualifierName": [
        "epidemiology",
        "microbiology"
      ],
      "DescriptorName": "Cross Infection"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Outbreaks"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Drug Resistance, Multiple, Bacterial"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Electrophoresis, Gel, Pulsed-Field"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "epidemiology"
      ],
      "DescriptorName": "France"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Hospitals, University"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Integrons"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Molecular Sequence Data"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Phylogeny"
    },
    {
      "QualifierName": [
        "drug therapy",
        "epidemiology",
        "genetics"
      ],
      "DescriptorName": "Pseudomonas Infections"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "Pseudomonas aeruginosa"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics"
      ],
      "DescriptorName": "beta-Lactamases"
    }
  ]
}